Red River Talc, LLC was created on August 19, 2024 as Johnson & Johnson's third bankruptcy attempt to resolve talc litigation, filing a prepackaged Chapter 11 in the Southern District of Texas on September 20, 2024 to implement a Section 524(g) trust for approximately 90,000 ovarian and gynecological cancer claims from 62,000+ claimants. The debtor proposed $9 billion in trust funding over 25 years (characterized as $7.9 billion capped and $6.5 billion NPV by the U.S. Trustee) and claimed 83% prepetition acceptance. However, immediate objections from a creditor coalition and the U.S. Trustee (calling the filing "textbook bad faith") forced a combined confirmation and dismissal trial. On March 31, 2025, Judge Christopher M. Lopez dismissed the case for cause, finding the plan contained impermissible nonconsensual third-party releases, that the Section 524(g) structure was not feasible as proposed, and that the prepetition solicitation process suffered from serious irregularities. J&J declined to appeal, leaving claimants to pursue litigation directly.